5248

    524412

    AAREYDRUGS

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    AAREY DRUGS & PHARM LTD Share Price Today

    AAREY DRUGS & PHARM LTD is currently trading at ₹77.97, down by ₹1.58 from the previous close. The stock touched an intraday high of ₹77.97 and a low of ₹77.97 during the latest trading session. Over the past one year, AAREY DRUGS & PHARM LTD has delivered a return of 14.34%, while the stock has gained 0.26% in the last one month.

    AAREY DRUGS & PHARM LTD performance

    Today’s low Today’s high
    ₹ 77.97 ₹ 77.97
    ₹ 77.97
    52 week low 52 week high
    ₹ 50.31 ₹ 100.00
    ₹ 77.97
    Open Price ₹ 77.97
    Prev. Close ₹ 79.56
    Volume (Shares) 7345.00
    Total traded value ₹ 5.72
    Upper Circuit ₹ 81.15
    Lower Circuit ₹ 77.97
    info

    Investment Returns

    Over 1 Month 0.26% Over 3 Months 6.05% Over 6 Months 23.59% Over 1 Year 14.34%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    AAREY DRUGS & PHARM LTD fundamentals


    • Market cap (Cr) 221.10
    • P/E Ratio (TTM) 58.64
    • Beta 1.46
    • Book Value / share 53.01
    • Return on equity 2.96%
    • EPS (TTM) 1.40
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 1.56
    info icon alternate text
    • Market cap (Cr) 228.10
    • P/E Ratio (TTM) 58.64
    • Beta 1.40
    • Book Value / share 53.01
    • Return on equity 2.96%
    • EPS (TTM) 1.40
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 1.56
    info icon alternate text

    AAREY DRUGS & PHARM LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 189.47
    Operating Expense 187.76
    Net Profit 1.56
    Net Profit Margin (%) 0.82
    Earnings Per Share (EPS) 0.55
    EBITDA 3.91
    Effective Tax Rate (%) -21.87
    Particulars DEC 2025 (Values in Cr)
    Revenue 96.43
    Operating Expense 99.69
    Net Profit 0.57
    Net Profit Margin (%) 0.59
    Earnings Per Share (EPS) 0.20
    EBITDA 2.67
    Effective Tax Rate (%) 38.04
    Particulars SEP 2025 (Values in Cr)
    Revenue 84.16
    Operating Expense 83.47
    Net Profit 1.02
    Net Profit Margin (%) 1.21
    Earnings Per Share (EPS) 0.36
    EBITDA 3.43
    Effective Tax Rate (%) 31.08
    Particulars JUN 2025 (Values in Cr)
    Revenue 102.21
    Operating Expense 102.03
    Net Profit 1.37
    Net Profit Margin (%) 1.34
    Earnings Per Share (EPS) 0.48
    EBITDA 3.26
    Effective Tax Rate (%) 20.80
    Particulars MAR 2025 (Values in Cr)
    Revenue 108.10
    Operating Expense 114.00
    Net Profit 0.47
    Net Profit Margin (%) 0.43
    Earnings Per Share (EPS) 0.17
    EBITDA 3.34
    Effective Tax Rate (%) 70.55
    Particulars MAR 2026 (Values in Cr)
    Revenue 472.27
    Operating Expense 472.95
    Net Profit 3.97
    Net Profit Margin (%) 0.84
    Earnings Per Share (EPS) 1.39
    EBITDA 13.26
    Effective Tax Rate (%) 26.80
    Particulars MAR 2025 (Values in Cr)
    Revenue 473.94
    Operating Expense 477.65
    Net Profit 4.02
    Net Profit Margin (%) 0.84
    Earnings Per Share (EPS) 1.43
    EBITDA 12.70
    Effective Tax Rate (%) 34.09
    Particulars MAR 2024 (Values in Cr)
    Revenue 395.62
    Operating Expense 397.24
    Net Profit 4.68
    Net Profit Margin (%) 1.18
    Earnings Per Share (EPS) 1.84
    EBITDA 11.42
    Effective Tax Rate (%) 12.35
    Particulars MAR 2023 (Values in Cr)
    Revenue 418.96
    Operating Expense 415.67
    Net Profit 3.78
    Net Profit Margin (%) 0.90
    Earnings Per Share (EPS) 1.49
    EBITDA 10.46
    Effective Tax Rate (%) 37.20
    Particulars MAR 2022 (Values in Cr)
    Revenue 492.68
    Operating Expense 485.40
    Net Profit 6.54
    Net Profit Margin (%) 1.32
    Earnings Per Share (EPS) 2.72
    EBITDA 14.02
    Effective Tax Rate (%) 34.69
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 46.90
    ROE % 2.96
    ROCE % 6.38
    Total Debt to Total Equity 0.24
    EBITDA Margin 2.68
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 45.57
    ROE % 3.74
    ROCE % 6.09
    Total Debt to Total Equity 0.28
    EBITDA Margin 2.89
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 44.43
    ROE % 3.26
    ROCE % 6.28
    Total Debt to Total Equity 0.22
    EBITDA Margin 2.49
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 43.85
    ROE % 6.16
    ROCE % 9.79
    Total Debt to Total Equity 0.15
    EBITDA Margin 2.86
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 41.29
    ROE % 6.81
    ROCE % 9.38
    Total Debt to Total Equity 0.19
    EBITDA Margin 3.35
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.47
    Total Assets 290.59
    Total Liabilities 290.59
    Total Equity 138.48
    Share Outstanding 2
    Price to Book Ratio 0.72
    Return on Assets (%) 1.38
    Return on Capital (%) 2.32
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.59
    Total Assets 303.29
    Total Liabilities 303.29
    Total Equity 132.77
    Share Outstanding 2
    Price to Book Ratio 0.98
    Return on Assets (%) 1.54
    Return on Capital (%) 2.85
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.70
    Total Assets 291.32
    Total Liabilities 291.32
    Total Equity 117.40
    Share Outstanding 2
    Price to Book Ratio 0.53
    Return on Assets (%) 1.29
    Return on Capital (%) 2.43
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.19
    Total Assets 245.16
    Total Liabilities 245.16
    Total Equity 113.63
    Share Outstanding 2
    Price to Book Ratio 0.94
    Return on Assets (%) 2.67
    Return on Capital (%) 5.13
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.64
    Total Assets 233.03
    Total Liabilities 233.03
    Total Equity 98.86
    Share Outstanding 2
    Price to Book Ratio 0.56
    Return on Assets (%) 2.79
    Return on Capital (%) 5.57
    Particulars MAR 2025 (Values in Cr)
    Net Income 6.10
    Cash from Operations 12.20
    Cash from Investing -5.93
    Cash from Financing -4.48
    Net change in Cash -0.12
    Free Cash Flow 17.41
    Particulars MAR 2024 (Values in Cr)
    Net Income 5.34
    Cash from Operations -1.66
    Cash from Investing -1.70
    Cash from Financing 5.58
    Net change in Cash 0.88
    Free Cash Flow -0.94
    Particulars MAR 2023 (Values in Cr)
    Net Income 6.00
    Cash from Operations 0.99
    Cash from Investing 0.44
    Cash from Financing 1.35
    Net change in Cash 0.51
    Free Cash Flow 2.04
    Particulars MAR 2022 (Values in Cr)
    Net Income 10.02
    Cash from Operations 4.08
    Cash from Investing -3.21
    Cash from Financing 2.25
    Net change in Cash -0.45
    Free Cash Flow 6.29
    Particulars MAR 2021 (Values in Cr)
    Net Income 8.30
    Cash from Operations 7.14
    Cash from Investing -2.87
    Cash from Financing -2.45
    Net change in Cash 0.14
    Free Cash Flow 10.02
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.48 13.06 1.52 241.24 23.12 38.85
    BLISS GVS PHARMA LTD 522.90 42.03 4.64 5545.68 118.35 552.90
    CIPLA LTD 1438.55 30.53 3.37 116212.59 1165.55 1672.20
    FERMENTA BIOTECH LTD. 450.85 19.89 3.26 1326.90 256.40 480.00
    GLAXOSMITHKLINE PHARMA LT 2463.55 43.37 18.40 41734.02 2088.00 3258.50
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.48 22.01 4.05 241.24 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 536.60 24.05 4.19 1551.34 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8185.10 106.90 23.44 20462.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 522.90 56.53 4.80 5545.68 118.35 552.90

    AAREY DRUGS & PHARM LTD shareholding pattern

    Holding
    56.49%
    37.71%
    4.17%
    1.62%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    AAREY DRUGS & PHARM LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    77.97 -1.99 redarrow
    red-green-graph indicator
    14 Bearish
    2 Bullish
    • 5 Days 82.40
    • 26 Days 84.30
    • 10 Days 84.00
    • 50 Days 82.90
    • 12 Days 84.30
    • 100 Days 80.00
    • 20 Days 84.50
    • 200 Days 76.30
    79.56 PIVOT
    First Support 79.56 First Resistance 79.56 Second Support 79.56 Second Resistance 79.56 Third Support 79.56 Third Resistance 79.56
    RSI 39.05 ADX 26.36 MACD -0.04 Williams % R -100.00 Commodity Channel Index (CCI) -115.40
    Date 2026-04-29 Week 159427.00 Same Day 134098.00 Month 131502.00
    1 Year 1.46 3 Year 1.04
    Over 1 Month
    0.26% down
    Over 1 Year
    14.34% down
    Over 3 Months
    6.05% down
    Over 3 Years
    34.42% down
    Over 6 Months
    23.59% down
    Over 5 Years
    12.91% down

    AAREY DRUGS & PHARM LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    13 Dec 2018 0.1 Interim 14 Dec 2018 Equity shares
    Ex-Date Ex-Bonus Ratio
    26 Jun 2012 25 Jun 2012 1:5
    Dividend date Dividend amount Dividend type Record date Instrument type
    13 Dec 2018 0.1 Interim 14 Dec 2018 Equity shares
    Ex-Date Ex-Bonus Ratio
    26 Jun 2012 25 Jun 2012 1:5

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Aarey Drugs & Pharmaceuticals Ltd?

    Answer Field

    Aarey Drugs & Pharmaceuticals Ltd share price is for NSE ₹ 77.97 & for BSE ₹ 80.45 as on Jul 15 2026 03:14 PM.

    What is the Market Cap of Aarey Drugs & Pharmaceuticals Ltd Share?

    Answer Field

    The market cap of Aarey Drugs & Pharmaceuticals Ltd for NSE ₹ 221.10 & for BSE ₹ 0.00 as on Jul 15 2026 03:14 PM.

    What is the 52 Week High and Low of Aarey Drugs & Pharmaceuticals Ltd?

    Answer Field

    The 52 Week High and Low of Aarey Drugs & Pharmaceuticals Ltd for NSE is ₹ 100.00 and ₹ 50.31 and for BSE is ₹ 100.00 and ₹ 50.40.

    What is 1 year return for Aarey Drugs & Pharmaceuticals Ltd?

    Answer Field

    The 1 year returns on the stock has been 14.34%.

    What is the P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 15 2026 03:14 PM the price-to-earnings (PE) ratio for Aarey Drugs & Pharmaceuticals Ltd share is 58.64.

    What is the PB ratio of Aarey Drugs & Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 15 2026 03:14 PM, the price-to-book (PB) ratio for Aarey Drugs & Pharmaceuticals Ltd share is 53.01.

    How to Buy Aarey Drugs & Pharmaceuticals Ltd Share?

    Answer Field

    You can trade in Aarey Drugs & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Aarey Drugs & Pharmaceuticals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Aarey Drugs & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Aarey Drugs & Pharmaceuticals Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |